Back to results
US 2025/0084080 A1Published application
Crystalline and salt forms of an nlrp3 inhibitor
AssigneeBioAge Labs, Inc.
InventorSanjeev Hukmichand Kothari
Life of this patent
Estimating the term…
Abstract
This disclosure provides crystalline forms of an NLRP3 inhibitor, and methods of making and using these forms.
Claims34
A crystalline form of 2-ethoxy-3′,5′-difluoro-N-((4-(hydroxymethyl)-1H-pyrazolo[4,3-c]pyridin-7-yl)methyl)-N-methyl-[1,1′-biphenyl]-4-carboxamide, or a pharmaceutically acceptable salt or hydrate thereof.
8-9. (canceled)
(canceled)
(canceled)
(canceled)
28-29. (canceled)
Dependencies are inferred from the claim text.